HEALTH & LIFE CO., LTD. Financials Health & Life Co., Ltd.
Equities
1781
TW0001781003
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.3 TWD | -1.92% |
|
-4.08% | -9.73% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 474.1 | 416.7 | 1,233 | 741.9 | 723 | 803.6 |
| Enterprise Value (EV) 1 | 406.3 | 403.5 | 1,013 | 676.6 | 755.6 | 766.3 |
| P/E ratio | -12.3 x | -5.45 x | 5.99 x | -11.9 x | -41.2 x | -24.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.77 x | 0.99 x | 1.59 x | 0.91 x | 0.91 x | 1.34 x |
| EV / Revenue | 0.66 x | 0.96 x | 1.31 x | 0.83 x | 0.95 x | 1.27 x |
| EV / EBITDA | -10.5 x | -6.4 x | -128 x | -7.52 x | -21.9 x | -26.2 x |
| EV / FCF | -5.3 x | -148 x | -10.2 x | -5.75 x | -8.87 x | 9.28 x |
| FCF Yield | -18.9% | -0.67% | -9.82% | -17.4% | -11.3% | 10.8% |
| Price to Book | 1.35 x | 1.57 x | 2.8 x | 1.96 x | 1.94 x | 2.4 x |
| Nbr of stocks (in thousands) | 47,408 | 47,408 | 47,408 | 47,408 | 47,408 | 47,408 |
| Reference price 2 | 10.00 | 8.790 | 26.00 | 15.65 | 15.25 | 16.95 |
| Announcement Date | 4/1/19 | 3/31/20 | 3/30/21 | 3/30/22 | 3/28/23 | 3/14/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 617.6 | 421.2 | 774.2 | 811.9 | 797.5 | 601.2 |
| EBITDA 1 | -38.72 | -63.08 | -7.906 | -89.91 | -34.51 | -29.21 |
| EBIT 1 | -57.05 | -78.36 | -16.78 | -96.89 | -44.39 | -41.06 |
| Operating Margin | -9.24% | -18.61% | -2.17% | -11.93% | -5.57% | -6.83% |
| Earnings before Tax (EBT) 1 | -46.42 | -74.97 | 264.5 | -83.3 | -15.46 | -37.56 |
| Net income 1 | -38.46 | -76.44 | 206 | -62.34 | -17.55 | -33.23 |
| Net margin | -6.23% | -18.15% | 26.61% | -7.68% | -2.2% | -5.53% |
| EPS 2 | -0.8112 | -1.612 | 4.340 | -1.315 | -0.3701 | -0.7009 |
| Free Cash Flow 1 | -76.72 | -2.723 | -99.49 | -117.6 | -85.23 | 82.6 |
| FCF margin | -12.42% | -0.65% | -12.85% | -14.48% | -10.69% | 13.74% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/1/19 | 3/31/20 | 3/30/21 | 3/30/22 | 3/28/23 | 3/14/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 32.6 | - |
| Net Cash position 1 | 67.8 | 13.2 | 220 | 65.4 | - | 37.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.9458 x | - |
| Free Cash Flow 1 | -76.7 | -2.72 | -99.5 | -118 | -85.2 | 82.6 |
| ROE (net income / shareholders' equity) | -10.3% | -24.8% | 58.3% | -15.2% | -4.67% | -9.39% |
| ROA (Net income/ Total Assets) | -6.1% | -8.4% | -1.33% | -6.78% | -3.52% | -3.4% |
| Assets 1 | 630.8 | 910.3 | -15,512 | 919 | 498.5 | 977.9 |
| Book Value Per Share 2 | 7.400 | 5.610 | 9.300 | 7.980 | 7.860 | 7.070 |
| Cash Flow per Share 2 | 3.350 | 2.980 | 9.140 | 4.220 | 3.300 | 3.180 |
| Capex 1 | 4.28 | 34.7 | 22.4 | 12.4 | 4.74 | 7.97 |
| Capex / Sales | 0.69% | 8.25% | 2.89% | 1.52% | 0.59% | 1.33% |
| Announcement Date | 4/1/19 | 3/31/20 | 3/30/21 | 3/30/22 | 3/28/23 | 3/14/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -9.73% | 22.24M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.01B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B |
- Stock Market
- Equities
- 1781 Stock
- Financials Health & Life Co., Ltd.
